Description
What is the use of tofersen for injection?
Tofersen is indicated to treat ALS patients associated with a mutation in the superoxide dismutase 1 (SOD1) gene (SOD1-ALS). Tofersen, sold under the brand name Qalsody, is a medication used for the treatment of amyotrophic lateral sclerosis (ALS). Tofersen is an antisense oligonucleotide that targets the production of superoxide dismutase 1, an enzyme whose mutant form is commonly associated with ALS. Tofersen is approved for medical use in the US and EU. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. Common side effects include fatigue, arthralgia, increased cerebrospinal (brain and spinal cord) fluid white blood cells, and myalgia.
SOD1-ALS is a type of genetic ALS associated with a change or mutation in the SOD1 gene.
Has Qalsody (tofersen) been launched in India?
Patient Access Facilitation for Qalsody (tofersen) for injection
To give request – contact sourcing facilitation team
Company Name: Lucknow Speciality pharma





